|
|
| 3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene |
|
| CHEBI:65782 |
|
| 3beta,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene |
|
| A diterpenoid that is podocarpa-6,8,11,13-tetraene substituted by a methyl group at position 13 and hydroxy groups at position 3 and 12. Isolated from Securinega suffruticosa, it exhibits cytotoxicity towards human cancer cells. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
|
|
Molfile
XML
SDF
|
|
|
|
|
InChI=1S/C18H24O2/c1- 11-9-12-5-6-15-17(2,3)16(20)7-8-18(15,4)13(12)10-14(11)19/h5-6,9-10,15-16,19-20H,7-8H2,1-4H3/t15-,16-,18+/m0/s1 |
| SJWBGJZSWLEJSB-XYJFISCASA-N |
| [H][C@@]12C=Cc3cc(C)c(O)cc3[C@@]1(C)CC[C@H](O)C2(C)C |
|
|
Securinega suffruticosa
(NCBI:txid544674)
|
Found in
callus
(BTO:0001010).
See:
PubMed
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
|
Outgoing
|
3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene
(CHEBI:65782)
has parent hydride
podocarpane
(CHEBI:36548)
3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene
(CHEBI:65782)
has role
antineoplastic agent
(CHEBI:35610)
3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene
(CHEBI:65782)
has role
metabolite
(CHEBI:25212)
3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene
(CHEBI:65782)
is a
diterpenoid
(CHEBI:23849)
3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene
(CHEBI:65782)
is a
phenols
(CHEBI:33853)
3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene
(CHEBI:65782)
is a
secondary alcohol
(CHEBI:35681)
|
|
|
(3β)-13-methylpodocarpa-6,8,11,13-tetraene-3,12-diol
|
|
10272584
|
Reaxys Registry Number
|
Reaxys
|
|
16327202
|
PubMed citation
|
Europe PMC
|
|
